Radionuclide imaging and treatment of thyroid cancer

被引：0

作者：

Wang, Xiu Juan ^{[1
]}

Li, Xian Feng ^{[2
]}

Ren, Yuan ^{[1
]}

机构：

[1] Shan Xi Tumor Hosp, Dept Nucl Med, Taiyuan 030013, Shan Xi, Peoples R China

[2] Shan Xi Med Univ, Dept Nucl Med, Hosp 1, Taiyuan 030012, Shan Xi, Peoples R China

来源：

FRONTIERS IN BIOSCIENCE-LANDMARK | 2016年 / 21卷

关键词：

Thyroid Cancer; Radionuclide Imaging; Therapy; Review; SODIUM-IODIDE SYMPORTER; PRETARGETED RADIOIMMUNOTHERAPY; SOMATOSTATIN ANALOGS; DISTANT METASTASES; I-124; PET; BODY SCAN; THERAPY; CARCINOMA; PAPILLARY; I-131;

D O I：

10.2741/4449

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Over the past decades, the diagnostic methods and therapeutic tools for thyroid cancer (TC) have been greatly improved. In addition to the classical method of ingestion of radioactive iodine-131 (I-131) and subsequent I-123 and I-124 positron emission tomography (PET) in therapy and examination, I-124 PET-based 3-dimensional imaging, Ga-68-labeled [1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid]-1-NaI(3)-octreotide (DOTANOC) PET/computed tomography (CT), Tc-99m tetrofosmin, pre-targeted radioimmunotherapy, and peptide receptor radionuclide therapy have all been used clinically. These novel methods are useful in diagnosis and therapy of TC, but also have unavoidable adverse effects. In this review, we will discuss the development of nuclear medicine in TC examination and treatment.

引用

页码：1187 / 1193

页数：7

共 52 条

[31] Intraoperative radiation exposure with the use of 18F-FDG-guided thyroid cancer surgery [J].

Nalley, Charles ;

Wiebeck, Kim ;

Bartel, Twyla B. ;

Bodenner, Donald ;

Stack, Brendan C., Jr. .

OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2010, 142 (02) :281-283

[32] The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid Gland [J].

Nixon, Iain J. ;

Whitcher, Monica M. ;

Palmer, Frank L. ;

Tuttle, R. Michael ;

Shaha, Ashok R. ;

Shah, Jatin P. ;

Patel, Snehal G. ;

Ganly, Ian .

THYROID, 2012, 22 (09) :884-889

[33] Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors [J].

Pellegriti, Gabriella ;

Frasca, Francesco ;

Regalbuto, Concetto ;

Squatrito, Sebastiano ;

Vigneri, Riccardo .

JOURNAL OF CANCER EPIDEMIOLOGY, 2013, 2013

[34] Update on the Cytologic and Molecular Features of Medullary Thyroid Carcinoma [J].

Pusztaszeri, Marc P. ;

Bongiovanni, Massimo ;

Faquin, William C. .

ADVANCES IN ANATOMIC PATHOLOGY, 2014, 21 (01) :26-35

[35] Radioactive iodine induces clastogenic and age-dependent aneugenic effects in lymphocytes of thyroid cancer patients as revealed by interphase FISH [J].

Ramirez, MJ ;

Surralles, J ;

Galofre, P ;

Creus, A ;

Marcos, R .

MUTAGENESIS, 1997, 12 (06) :449-455

[36] Usefulness of [99mTc]MIBI and [18F]fluorodeoxyglucose for imaging recurrent medullary thyroid cancer and hyperparathyroidism in MEN 2a syndrome [J].

Roelants, V ;

Michel, L ;

Lonneux, M ;

Lacrosse, M ;

Delgrange, E ;

Donckier, JE .

ACTA CLINICA BELGICA, 2001, 56 (06) :373-377

[37] 18F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma [J].

Salaun, Pierre-Yves ;

Campion, Loic ;

Ansquer, Catherine ;

Frampas, Eric ;

Mathieu, Cedric ;

Robin, Philippe ;

Bournaud, Claire ;

Vuillez, Jean-Philippe ;

Taieb, David ;

Rousseau, Caroline ;

Drui, Delphine ;

Mirallie, Eric ;

Borson-Chazot, Francoise ;

Goldenberg, David M. ;

Chatal, Jean-Francois ;

Barbet, Jacques ;

Kraeber-Bodere, Francoise .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (08) :1501-1510

[38] Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement [J].

Salaun, Pierre-Yves ;

Campion, Loic ;

Bournaud, Claire ;

Faivre-Chauvet, Alain ;

Vuillez, Jean-Philippe ;

Taieb, David ;

Ansquer, Catherine ;

Rousseau, Caroline ;

Borson-Chazot, Francoise ;

Bardet, Stephane ;

Oudoux, Aurore ;

Cariou, Bertrand ;

Mirallie, Eric ;

Chang, Chien-Hsing ;

Sharkey, Robert M. ;

Goldenberg, David M. ;

Chatal, Jean-Francois ;

Barbet, Jacques ;

Kraeber-Bodere, Francoise .

JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (08) :1185-1192

[39]

SCHLUMBERGER M, 1988, J NUCL MED, V29, P1790

[40] Expression of the sodium iodide symporter in differentiated thyroid cancer [J].

Schmitz, G ;

Füzesi, L ;

Struck, J ;

Siefker, U ;

Hamann, A ;

Sahlmann, CO ;

Hüfner, M ;

Meller, J .

NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2005, 44 (03) :86-93

← 1 2 3 4 5 6 →